• About
    • Login
    View Item 
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDepartmentThis CollectionBy Issue DateAuthorsTitlesSubjectsDepartment

    My Account

    LoginRegister

    Disentangling Sources of Phenotypic Variability in Oncogene-addicted Cancers

    Hayford, Corey Eduardo
    0000-0002-3006-4852
    : http://hdl.handle.net/1803/16576
    : 2021-03-08

    Abstract

    Tumor heterogeneity and plasticity are key contributors to treatment insensitivity and eventual recurrence in oncogene-addicted cancers. Sources of this variability have been ascribed to genetic, epigenetic, stochastic, and multiple other sources. Multi-omics datasets, single-cell lineage tracing, and quantitative drug response experiments were performed on multiple in vitro models prior to and during the course of targeted therapy treatment to assign sources of tumor variability to differential treatment outcomes. In a study dedicated to tumor heterogeneity, we identified that EGFR-mutant lung cancer cell line ‘versions’, evolved independently in culture at different institutions, exhibited genetic differences, while single-cell derived sublines displayed predominately epigenetic differences, leading to variable drug response profiles. A single subline showed clear functional genetic differences, which led to resistance. A study of tumor plasticity identified a novel drug-tolerant ‘idling’ population state in the response of BRAF-mutant melanoma cell lines to treatment. Lineage tracing coupled to single-cell gene expression provided evidence for a mathematical model-predicted mechanism of epigenetic state transitions, by which drug modifies the phenotypic landscape, resulting in cell population re-equilibration to the modified landscape. Transcriptomic and epigenomic profiling pointed towards ion channel activity as being characteristic of the drug-modified ‘idling’ landscape, which was subsequently targeted by a form of targeted cell death. Together, these studies support for a multi-tier view of tumor variability, where a complex network of sources contribute to variable treatment outcomes and evasion. Furthermore, these results advocate for novel therapeutic strategies that target network control points in conjunction with traditional targeted therapies.
    Show full item record

    Files in this item

    Icon
    Name:
    HAYFORD-DISSERTATION-2021.pdf
    Size:
    7.211Mb
    Format:
    PDF
    View/Open
    Name:
    Thesis_v4.docx
    Size:
    15.48Mb
    Format:
    Microsoft Word 2007
    View/Open

    This item appears in the following collection(s):

    • Electronic Theses and Dissertations

    Connect with Vanderbilt Libraries

    Your Vanderbilt

    • Alumni
    • Current Students
    • Faculty & Staff
    • International Students
    • Media
    • Parents & Family
    • Prospective Students
    • Researchers
    • Sports Fans
    • Visitors & Neighbors

    Support the Jean and Alexander Heard Libraries

    Support the Library...Give Now

    Gifts to the Libraries support the learning and research needs of the entire Vanderbilt community. Learn more about giving to the Libraries.

    Become a Friend of the Libraries

    Quick Links

    • Hours
    • About
    • Employment
    • Staff Directory
    • Accessibility Services
    • Contact
    • Vanderbilt Home
    • Privacy Policy